Lobe sciences announces $341,425 cad private placement for general corporate purposes

Not for distribution to united states news wire services or for dissemination in the united states vancouver, british columbia / access newswire / july 29, 2025 / lobe sciences ltd. ("lobe sciences" or the "company") (cse:lobe)(otcqb:lobef)(fwb:lobe.f), a biopharmaceutical company focused on developing therapeutics for rare and underserved diseases, is pleased to announce a non-brokered private placement (the "offering") of up to 8,535,625 common share of the company (each, a "share") at a price of $0.04 per share for gross proceeds of up to $341,425 cad.
GM Ratings Summary
GM Quant Ranking